Envisagenics, Cancer Research Horizons, and Queen Mary University of London Announce Strategic Collaboration Agreement

/PRNewswire/ -- Envisagenics, an Artificial Intelligence ("AI")-driven biotechnology company that delivers therapies for RNA splicing diseases, today announced...

Related Keywords

China ,Malta ,Paris ,France General ,France ,United Kingdom ,London ,City Of ,Singapore ,Envisagenic Splicecore ,Prnewswire Envisagenics ,Bradley Harris ,Tony Hickson ,Martin Akerman ,Ellie Bennett ,Sophia Prout ,Cancer Research Horizons ,Cancer Research Horizon Contact ,Linkedin ,National Cancer Institute ,Queen Mary University Of London Contact ,Twitter ,Cold Spring Harbor Laboratory ,Youtube ,Cancer Research United Kingdom ,Queen Mary University Of London ,Cancer Research Horizon ,National Institute ,Queen Mary Barts Cancer Institute ,Artificial Intelligence ,Queen Mary University ,Queen Mary ,Chief Business Officer ,Barts Cancer Institute ,Artificial Intelligence Driven ,General Medical Sciences ,National Cancer ,Research Horizons ,Mary University ,Envisagenics ,